Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.17 USD | +0.38% | -0.83% | -28.01% |
Feb. 06 | Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating | MT |
Feb. 01 | Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating | MT |
Business Summary
Number of employees: 376
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Device
79.8
%
| 72 | 72.4 % | 106 | 79.8 % | +46.13% |
In Vitro Diagnostics
20.2
%
| 28 | 27.6 % | 27 | 20.2 % | -2.76% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
82.0
%
| 74 | 74.0 % | 109 | 82.0 % | +46.99% |
Foreign
18.0
%
| 26 | 26.0 % | 24 | 18.0 % | -8.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gary Maharaj
CEO | Chief Executive Officer | 61 | 10-12-26 |
Timothy Arens
DFI | Director of Finance/CFO | 57 | 07-01-31 |
Teri L. Sides
PRN | Corporate Officer/Principal | 55 | 18-10-31 |
John Manders
AUD | Comptroller/Controller/Auditor | 43 | 17-02-28 |
Joseph Stich
HRO | Human Resources Officer | 59 | 10-03-07 |
Gordon Weber
LAW | General Counsel | 61 | 20-05-12 |
Charles Olson
PRN | Corporate Officer/Principal | 60 | 01-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Kalich
BRD | Director/Board Member | 77 | 14-02-16 |
Susan Knight
CHM | Chairman | 70 | 08-01-28 |
José Bedoya
BRD | Director/Board Member | 68 | 01-12-31 |
David Dantzker
BRD | Director/Board Member | 80 | 11-01-04 |
Gary Maharaj
CEO | Chief Executive Officer | 61 | 10-12-26 |
Lisa Heine
BRD | Director/Board Member | 61 | 17-04-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,236,000 | 13,702,309 ( 96.25 %) | 0 | 96.25 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.01% | 371M | |
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+2.21% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+11.32% | 25.66B |
- Stock Market
- Equities
- SRDX Stock
- Company Surmodics, Inc.